Bayer AG (BAYRY) reports modest sales growth and debt reduction amid financial headwinds and strategic challenges.

Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline ...

Bayer has set itself ambitious global sustainability targets to be achieved by 2030, which include supporting vulnerable or ...

The center, which broke ground in 2023 in the Beijing Economic-Technological Development Area — aka Beijing E-Town — is the ...

Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares ...

Facing thousands of lawsuits and seeking protection from lawmakers, Bayer is using ads, lobbying and third-party mouthpieces ...

Bayer’s Crop Sciences division holds significant potential despite glyphosate issues. See why BAYRY stock is undervalued and ...

Manns said Bayer “urgently” needed to reduce its net financial debt. The consensus forecast from analysts is that, despite a radical dividend cut in 2024, debt declined by only €1.2bn to €33.3bn at ...

As conversations around women's health gain momentum, efforts to dismantle long-held stigmas and barriers are emerging across health, education, and livelihoods. The growing emphasis on accessible ...

Sen. Rosemary Bayer is proposing the state implement new laws regarding older drivers after a fatal October crash involving a ...

Find insight on Merck KGaA, Bayer, Jazz Pharmaceuticals and the use of AI in China’s healthcare sector in the latest Market ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...